Kamal Albarazanji

Kamal AlbarazanjiKamal Albarazanji
KA

Kamal Albarazanji

Senior Director of Metabolic Research at BioGene Therapeutics Inc.

Rate

About

Dr. Kamal Albarazanji is the Senior Director of Metabolic Research at BioGene Therapeutics Inc. He possesses extensive experience in in vivo pharmacology, target validation, and translational research, with a focus on metabolic diseases, obesity, and diabetes treatments. Dr. Albarazanji has held notable roles at SmithKline Beecham (now GSK) and has authored over 20 peer-reviewed manuscripts and holds numerous patents.
Frequently asked

Who is Kamal Albarazanji?

Dr. Kamal Albarazanji is the Senior Director of Metabolic Research at BioGene Therapeutics Inc. He possesses extensive experience in in vivo pharmacology, target validation, and translational research, with a focus on metabolic diseases, obesity, and diabetes treatments. Dr. Albarazanji has held notable roles at SmithKline Beecham (now GSK) and has authored over 20 peer-reviewed manuscripts and ho…

What is Kamal Albarazanji's current role?

Kamal Albarazanji is currently Senior Director of Metabolic Research at BioGene Therapeutics Inc..

Comments

No comments yet. Be the first to share your take.

Profile

About Kamal Albarazanji

Kamal Albarazanji is Senior Director of Metabolic Research at BioGene Therapeutics Inc.. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.